Trial Profile
Pelvic Floor Trigger Point Injection With OnabotulinumtoxinA for the Treatment of Severe Myofascial Pelvic Pain (MPP) - A Randomized, Controlled Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Myofascial pain
- Focus Therapeutic Use
- Acronyms BotoxMPP
- 06 May 2022 Status changed from recruiting to completed.
- 04 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 03 Jul 2014 New trial record